The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Cattran, D. C., Coppo, R., Cook, H. T., Feehally, J., Roberts, I. S. D., Troyanov, S., Alpers, C. E., Amore, A., Barratt, J., et al. (2009) · Kidney International · doi:10.1038/ki.2009.243 · Cited by 1,235
Self-citationCoppo, R., on behalf of the VALIGA study of the ERA-EDTA Immunonephrology Working Group, Troyanov, S., Bellur, S., Cattran, D., Cook, H. T., Feehally, J., Roberts, I. S. D., Morando, L., Camilla, R., et al. (2014) · Kidney International · doi:10.1038/ki.2014.63 · Cited by 498
Self-citationPredicting progression in IgA nephropathy
Bartosik, L. P., Lajoie, G., Sugar, L., & Cattran, D. C. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.27689 · Cited by 363
Self-citationA Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy
Haas, M., Verhave, J. C., Liu, Z.-H., Alpers, C. E., Barratt, J., Becker, J. U., Cattran, D., Cook, H. T., Coppo, R., Feehally, J., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016040433 · Cited by 307
Self-citationThe MEST score provides earlier risk prediction in lgA nephropathy
Barbour, S. J., Espino-Hernandez, G., Reich, H. N., Coppo, R., Roberts, I. S. D., Feehally, J., Herzenberg, A. M., Cattran, D. C., Bavbek, N., Cook, T., et al. (2016) · Kidney International · doi:10.1038/ki.2015.322 · Cited by 292
Self-citationAutoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy
Berthoux, F., Suzuki, H., Thibaudin, L., Yanagawa, H., Maillard, N., Mariat, C., Tomino, Y., Julian, B. A., & Novak, J. (2012) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012010053 · Cited by 272
Prognosis in IgA Nephropathy: 30-Year Analysis of 1,012 Patients at a Single Center in Japan
Moriyama, T., Tanaka, K., Iwasaki, C., Oshima, Y., Ochi, A., Kataoka, H., Itabashi, M., Takei, T., Uchida, K., & Nitta, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091756 · Cited by 259
Association of C4d Deposition with Clinical Outcomes in IgA Nephropathy
Espinosa, M., Ortega, R., Sánchez, M., Segarra, A., Salcedo, M. T., González, F., Camacho, R., Valdivia, M. A., Cabrera, R., López, K., et al. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09710913 · Cited by 218
Validation of the Oxford classification of IgA nephropathy
Herzenberg, A. M., Fogo, A. B., Reich, H. N., Troyanov, S., Bavbek, N., Massat, A. E., Hunley, T. E., Hladunewich, M. A., Julian, B. A., Fervenza, F. C., et al. (2011) · Kidney International · doi:10.1038/ki.2011.126 · Cited by 211
Self-citationCoppo, R., Troyanov, S., Camilla, R., Hogg, R. J., Cattran, D. C., Terence Cook, H., Feehally, J., Roberts, I. S. D., Amore, A., Alpers, C. E., et al. (2010) · Kidney International · doi:10.1038/ki.2010.43 · Cited by 204
Self-citation
Cited by
Bajema, I. M., Wilhelmus, S., Alpers, C. E., Bruijn, J. A., Colvin, R. B., Cook, H. T., D’Agati, V. D., Ferrario, F., Haas, M., Jennette, J. C., et al. (2018) · Kidney International · doi:10.1016/j.kint.2017.11.023 · Cited by 1,058
Self-citationEvaluating a New International Risk-Prediction Tool in IgA Nephropathy
Barbour, S. J., Coppo, R., Zhang, H., Liu, Z.-H., Suzuki, Y., Matsuzaki, K., Katafuchi, R., Er, L., Espino-Hernandez, G., Kim, S. J., et al. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.0600 · Cited by 478
Self-citationLv, J., Wong, M. G., Hladunewich, M. A., Jha, V., Hooi, L. S., Monaghan, H., Zhao, M., Barbour, S., Jardine, M. J., Reich, H. N., et al. (2022) · JAMA · doi:10.1001/jama.2022.5368 · Cited by 354
Self-citationProteinuria Reduction as a Surrogate End Point in Trials of IgA Nephropathy
Thompson, A., Carroll, K., A. Inker, L., Floege, J., Perkovic, V., Boyer-Suavet, S., W. Major, R., I. Schimpf, J., Barratt, J., Cattran, D. C., et al. (2019) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08600718 · Cited by 317
Self-citationA Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy
Mathur, M., Barratt, J., Chacko, B., Chan, T. M., Kooienga, L., Oh, K.-H., Sahay, M., Suzuki, Y., Wong, M. G., Yarbrough, J., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2305635 · Cited by 239
Self-citationThe pathogenesis of IgA nephropathy and implications for treatment
Cheung, C. K., Alexander, S., Reich, H. N., Selvaskandan, H., Zhang, H., & Barratt, J. (2025) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00885-3 · Cited by 222
Self-citationRovin, B. H., Barratt, J., Cook, H. T., Noronha, I. L., Reich, H. N., Suzuki, Y., Tang, S. C. W., Trimarch, H., & Floege, J. (2025) · Kidney International · doi:10.1016/j.kint.2025.04.004 · Cited by 206
Self-citationHayashi, K., Hishikawa, A., Hashiguchi, A., Azegami, T., Yoshimoto, N., Nakamichi, R., Tokuyama, H., & Itoh, H. (2020) · Scientific Reports · doi:10.1038/s41598-019-57140-0 · Cited by 25
IgA nephropathy: Update on pathogenesis and treatment
Ramsawak, S., Cohen, S., Linares, A., & Cavanaugh, C. (2025) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.92a.24105 · Cited by 23
The expanding role of biomarkers in the management of IgA nephropathy
Jain, K., & Rizk, D. V. (2026) · Kidney International Supplements · doi:10.1016/j.kisu.2026.01.004 · Cited by 6
Individualised treatment effects of corticosteroids in IgA nephropathy
Hölscher, D. L., Schmitz, N. E. J., Niggemeier, L., Pilva, P., Strauch, M., Tesar, V., Barratt, J., Roberts, I. S. D., Coppo, R., Barisoni, L., et al. (2026) · eBioMedicine · doi:10.1016/j.ebiom.2026.106396 · Cited by 2
“Nephropathology is a cornerstone in the diagnostic assessment for IgAN, with the Oxford classification (MEST-C) established as the standard histologic scoring system for patient risk prognostication.”
Self-citationCheung, C. K., & Mariani, L. H. (2026) · Kidney International Supplements · doi:10.1016/j.kisu.2026.01.003 · Cited by 2
Kidney biopsy in the diagnosis of immunoglobulin A nephropathy
Campbell, K. N., Chang, A., & Vivarelli, M. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1882638
Metadata
- Authors
- Trimarchi, H., Barratt, J., Cattran, D. C., Cook, H. T., Coppo, R., Haas, M., Liu, Z.-H., Roberts, I. S. D., Yuzawa, Y., Zhang, H., Feehally, J., Alpers, C. E., Asunis, A. M., Barbour, S., Becker, J. U., Ding, J., Espino, G., Ferrario, F., Fogo, A., Hladunewich, M., Joh, K., Katafuchi, R., Lv, J., Matsuzaki, K., Nakanishi, K., Pani, A., Perera, R., Perkowska-Ptasinska, A., Reich, H., Shima, Y., Soares, M. F., Suzuki, Y., Takahashi, K., Troyanov, S., Verhave, J. C., Wang, S., Weening, J., Wyatt, R., Yoshikawa, N., & Zeng, C.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2017-05
- Volume
- 91
- Issue
- 5
- Pages
- 1014-1021
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W2602196428
- Cited by
- 1,192
- References
- 22
- FWCI
- 64.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.